Detalles de la búsqueda
1.
Initial Total Bilirubin and Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Drug-Eluting Stents.
Circ J;
80(6): 1437-44, 2016 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27151334
2.
Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI.
Int J Cardiol;
168(1): 207-11, 2013 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23106905
3.
Neutrophil to Lymphocyte Ratio Predicts Long-Term Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Korean Circ J;
43(2): 93-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23508782
4.
High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting.
Int J Cardiol;
167(5): 1877-81, 2013 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22682702
5.
"Angiographic late catch-up" phenomenon after sirolimus-eluting stent implantation.
Int J Cardiol;
160(1): 48-52, 2012 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21824671
Resultados
1 -
5
de 5
1
Próxima >
>>